Not everyone is thrilled about the impending mega-merger of medtech titans Medtronic (NYSE:MDT) and Covidien (NYSE:COV). Although investors have rallied around the $43 billion deal and have lauded its structure as a corporate inversion, many stockholders are angry that they’re being stuck with a tax penalty.
Some shareholders have sued to block the merger, but others showed up in person at Medtronic’s latest annual conference to voice their concerns, according to local reports. elp employers find you! Check out all the jobs and post your resume.
